$1 Billion         |         Rank #2324

Who is Leonard Schleifer

Schleifer took Regeneron public in 1991; he owns nearly 4% of the company’s common stock.
Sales of Regeneron’s blockbuster drug Eylea, a treatment for macular degeneration, reached $4.6 billion in the U.S. in 2019.
Regeneron has developed six FDA-approved medicines.
In June 2020, Regeneron began clinical trials of a new antibody medicine to prevent and treat people with Covid-19. Coming from an average or middle class family, Leonard Schleifer is one those great persons who have stormed their way to the billionaires list on their own. And currently ranks at 2324 on billionaires list making him one of the wealthiest ever persons on the planet. He is currently 69.0 years old. As of today, Leonard Schleifer’s net worth is approximately 1 Billion.

Facts about Leonard Schleifer

To find out what is Leonard Schleifer Net Worth, how he got there and what is Leonard Schleifer Salary Per Day, Career, Biography and Childhood details, continue reading below.

Background of Leonard Schleifer

Leonard Schleifer was born on 07-07-52 in United States. The son of a sweater manufacturer, Schleifer grew up in Queens, New York. Schleifer attended Cornell on scholarship and dreamed of a medical career. Being raised in the same country, Leonard Schleifer spent most of his time in New York in the city of Tarrytown.

Leonard Schleifer net worth is estimated at 1 Billion Billion to date.

Professional Journey

Leonard Schleifer is currently working as CEO and Founder at the world famous Regeneron Pharmaceuticals. You will see him often in social media.  Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company. There was a time when he would have embraced the change that was coming.  He is one of the persons who are always trending in news. The son of a sweater manufacturer, Schleifer grew up in Queens, New York. In his youth, he was adventurous but unknown, but that was years ago. Schleifer took Regeneron public in 1991; he owns nearly 4% of the company’s common stock.
Sales of Regeneron’s blockbuster drug Eylea, a treatment for macular degeneration, reached $4.6 billion in the U.S. in 2019.
Regeneron has developed six FDA-approved medicines.
In June 2020, Regeneron began clinical trials of a new antibody medicine to prevent and treat people with Covid-19. He learnt to find the excitement that came with change. That curiosity had long left him to where he had come to loathe anything that put him out of his comfort zone. Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company.
It is to be noted that Leonard Schleifer is one of the selfmade billionaires in the world and stands at 2324 in most wealthy persons in the world.

FAQs

Here are a few most frequently asked questions about Leonard Schleifer:

How much is Leonard Schleifer worth?

Leonard Schleifer’s net worth is estimated to be 1 Billion.

How old is Leonard Schleifer?

Leonard Schleifer was born on 07-07-52, and is currently 69.0 years old.

What is Leonard Schleifer source of income?

Leonard Schleifer acquires most part of his wealth from pharmaceuticals.
 

Concluding Leonard Schleifer Net Worth

Currently with a net worth of 1 Billion, Leonard Schleifer stands at 2324 in the world billionaires list. And draws most of his wealth from pharmaceuticals. Hope you like this information about Leonard Schleifer. If you like this, then please share it with your friends. This above post is all about the estimated worth of Leonard Schleifer. Do you have any queries? Feel free to ask via comment section.

Disclaimer: Please keep in mind that this is an estimated net worth of Leonard Schleifer. Actual worth may vary a little. You can always get information by checking out Leaktown.com.